Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis

Abstract excerpt

BACKGROUND: Prurigo nodularis (PN) is a debilitating skin condition. When inadequate disease control is achieved or other systemic therapies are contraindicated, Janus kinase inhibitors (JAKis) may be considered, although real-world evidence remains limited. OBJECTIVES: To investigate clinical findings and treatment outcomes among patients diagnosed with PN and treated with JAKis in a real-world setting. METHODS:...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Dermatology and Skin Diseases
• Share to Psoriasis: Treatment and Pathogenesis